What Butisol Sodium Elixir Treats: Main Uses and Benefits

Butisol Sodium Elixir is commonly used to help with symptomatic relief in situations involving certain distressing symptoms. It is applied across therapeutic domains where short-term symptomatic assistance is needed and the induction of calmness may be part of symptomatic management.

The medication is relevant in conditions characterized by periods of heightened symptoms, such as transient insomnia and pre-operative apprehension. It is used for managing symptoms that interfere with daily functioning, such as trouble falling asleep and heightened emotional tension.

“The primary benefit is offering symptomatic relief that helps patients cope more steadily with difficult episodes of acute distress or sleep loss.”

Easing Acute Symptoms

This domain addresses the core use, applied when symptoms that interfere with daily functioning like trouble falling asleep, frequent nocturnal awakenings, and generalized nervousness create noticeable interference with necessary rest. The elixir helps address symptom clusters that may become intense or disruptive, and contributes to easing the overall symptom load.

The medication provides a general sedative benefit, applied during phases of increased distress to ease symptoms related to physical discomfort. This includes pre-procedural settings, where it is commonly used to help with pre-operative anxiety and agitation, supporting patients during difficult episodes by easing distress.

---

Quick Fact: Supportive Relief
Butisol Sodium Elixir assists with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods of emotional tension.

Regulatory References

1. NIH MedlinePlus Drug Information

Butisol Sodium Elixir is an intermediate-acting barbiturate used as a sedative or hypnotic in adults, often prescribed for short-term insomnia or pre-operative tension. Dosage may be adjusted for specific populations, but its use is generally restricted to adults.

---

Contraindications

This medication is contraindicated and must not be used if a patient has:

• A known allergy or hypersensitivity to butabarbital, any other barbiturate, or components of the elixir (such as tartrazine dye).
• A history of manifest or latent porphyria (an inherited enzyme disorder).
• Severe hepatic (liver) impairment or signs of hepatic coma.

---

Caution and Specific Populations

Close medical supervision and dose adjustment are required for individuals with certain existing health conditions. Patients should inform their healthcare provider if they have a history of:

Population/Condition	Key Consideration
Elderly/Debilitated	May be more sensitive to effects, increasing risk of falls, confusion, or paradoxical excitement. Lower doses are generally recommended.
Pregnancy/Breastfeeding	Use during pregnancy may harm the fetus. Barbiturates are present in breast milk.
Hepatic/Renal Impairment	Requires caution and dose reduction due to slower drug clearance.
Depression/Suicidal Thoughts	Barbiturates should be administered with extreme caution as they may worsen these conditions.
Respiratory Disease	Caution is advised due to the risk of respiratory depression.

Interactions with other medicines and products

Official regulatory information documents the potential for Butisol Sodium to interact with other medicines and products through two primary mechanisms: pharmacokinetic enzyme induction and pharmacodynamic additive effects.

Documented Drug and Substance Interactions

Interaction Category	Practical Constraint as per Regulatory Documents
Central Nervous System (CNS) Depressants (including alcohol)	Co-administration is restricted due to the additive depressant effects on the CNS, which increases the risk of serious side effects and complex behaviors.
Hormonal Contraceptives	Barbiturates are known to induce liver microsomal enzymes, which can increase the metabolism of hormonal birth control, making the contraceptive less effective. Alternative, non-hormonal methods are required.
Drugs Metabolized by Liver Enzymes	Due to enzyme induction, the medication may increase or alter the metabolism of other concurrently administered prescription drugs, potentially reducing their effectiveness.
Alcohol (Ethanol)	The concurrent use of Butisol Sodium and alcohol is to be avoided due to the enhanced depressant effect on the nervous system.

Condition-Specific Interaction Constraints

Butisol Sodium should not be administered to patients who are showing premonitory signs of hepatic coma. Furthermore, in cases of administration during pregnancy, official labeling notes that barbiturates cross the placental barrier and may be distributed throughout fetal tissues, potentially causing fetal damage.

Potentiating the Primary Inhibitory Pathway

Butisol Sodium is a barbiturate that works primarily by acting on the GABA-A receptor complex, the key site for the brain's major inhibitory neurotransmitter, Gamma-aminobutyric acid (GABA). By binding to an allosteric site on this receptor, the drug enhances the natural inhibitory action of GABA, resulting in decreased neuronal excitability. This action modulates pathways characterized by excessive or dysregulated signaling dynamics.

---

Inducing Neuronal Hyperpolarization via Chloride Flux

The potentiation of the GABA-A receptor causes its central channel to remain open for a longer duration, allowing a greater influx of negatively charged chloride ions (Cl^-) into the neuron. This surge of negative charge results in hyperpolarization—a state where the nerve cell's interior electrical potential becomes more negative. This change raises the activation threshold for the neuron, making the neuron less excitable and decreasing the probability of action potential propagation.

---

Global Central Nervous System (CNS) Depression

The net effect of increased GABA-mediated inhibition and neuronal hyperpolarization is a generalized depression of the Central Nervous System. This systemic effect influences regulatory feedback loops within neuronal networks. The physiological consequence is a dose-dependent decrease in generalized neural excitability, which is a characteristic of this class of compounds.

Butisol Sodium Elixir is administered exclusively by the oral route as a liquid solution and must be measured accurately for all dosage regimens. The medication's general use pattern is determined by the specific treatment purpose, which dictates both the required dose amount and the precise timing schedule.

Official Dosing Regimens

The labeled dosing for butabarbital sodium follows distinct patterns for its primary uses:

Purpose	Dose (Adult)	Frequency/Timing
Daytime Sedation	15 mg to 30 mg	3 to 4 times daily
Hypnotic/Insomnia	50 mg to 100 mg	Single dose at bedtime
Preoperative Sedation	50 mg to 100 mg	60 to 90 minutes before surgery

Administration Procedures and Constraints

The elixir must be shaken well before dispensing and must be measured precisely using a calibrated measuring device (such as a marked spoon, syringe, or cup). To ensure consistent absorption, the dose is generally taken on an empty stomach.

Usage is constrained by duration: treatment for insomnia is officially limited to two weeks. Furthermore, a reduced initial dose is required for sensitive populations, including older adults and those with hepatic impairment, as part of the established administration protocol. Following periods of prolonged administration, any discontinuation must be managed by a gradual withdrawal process.

Research Evidence / Overview of Studies for Butisol Sodium Elixir

Evidence for Use in Short-Term Insomnia

The evidence base for the use of butabarbital sodium to manage sleep problems centers around controlled sleep laboratory studies and historical clinical assessments of the intermediate-acting sedative-hypnotic drug class. Researchers conducting this research examined key outcomes related to sleep induction, such as the time needed to fall asleep (sleep latency), and how research examined sleep maintenance over the course of the night. These studies primarily focused on adult populations experiencing episodic or short-term difficulty sleeping.

Reports from these studies highlight a pattern where the outcomes measured for sleep induction and maintenance were captured in studies of short-term use, typically limited to approximately two weeks. Furthermore, the findings from controlled comparative research involving various short-acting and intermediate-acting barbiturates have historically been mixed, with some studies suggesting that these compounds do not produce distinctly different effects on sleep in measured outcomes. This research contributes to the broader evidence landscape by helping to contextualize how patients reported their experiences with short-term sleep symptoms.

---

Evidence for Use in Pre-Operative Sedation

Research exploring the use of butabarbital sodium for sedation prior to medical procedures relies on protocols involving single-dose administration and the long-standing clinical experience associated with this drug class. The studies monitored acute outcomes capturing phases of heightened symptom activity, such as apprehension or emotional tension, and evaluated measures of calmness immediately prior to the procedure. This research was evaluated in populations that include both adults and children requiring sedation before a procedure, with observations typically focused on the short time interval immediately before the event.

The evidence for this use is widely recognized in professional literature as part of the historical use profile for intermediate-acting sedatives. Findings describe patterns observed where the drug was evaluated for its role in achieving a state of sedation during these specific, acute episodes. The data contributes to understanding how this type of medication was utilized in specialized medical settings involving varying symptom burdens related to anxiety before a procedure.

Key Studies & References Barbiturates - StatPearls (NCBI Bookshelf)

Common questions about Butisol Sodium Elixir (FAQ)

Q: What is Butisol Sodium Elixir used for?

Butisol Sodium Elixir is a prescription medication indicated for use as a sedative or hypnotic. The specific uses are determined by a healthcare provider based on the patient's condition.

Q: What type of drug is Butisol Sodium Elixir?

Butisol Sodium (butabarbital sodium) is a barbiturate. Barbiturates are a class of medications that depress the central nervous system.

Q: How quickly does Butisol Sodium Elixir start to work?

The onset of effect for butabarbital sodium has been observed to occur within a certain timeframe, but individual results may vary. Patients should discuss expected timelines with their prescribing physician.

Q: Are there any known side effects?

Like all medications, Butisol Sodium Elixir may be associated with side effects. Commonly reported effects include drowsiness, confusion, and impaired coordination. A complete list of reported adverse reactions is available from the prescribing information.

Q: Can Butisol Sodium Elixir be taken with alcohol?

Butisol Sodium Elixir is a central nervous system depressant. Combining it with alcohol can increase drowsiness, respiratory depression, and other effects. It is generally recommended to avoid alcohol while using this medication.

Q: What should I do if I miss a dose?

If a dose is missed, a patient should consult the prescribing healthcare provider or pharmacist for guidance. They can provide instructions specific to the individual’s treatment plan.

Official Storage and Disposal Requirements

Butisol Sodium Elixir (Butabarbital Sodium Oral Solution) must be stored according to specific conditions defined in regulatory labeling to maintain its stability.

Storage Condition	Requirement
Temperature	Store at Controlled Room Temperature, between 20 C and 25 C (68 F to 77 F).
Protection	Keep away from heat, excess moisture, and direct light. Do not freeze the product.
Container	Keep the medication in the container it came in and keep the container tightly closed.
Child Safety	Store the elixir out of the sight and reach of children.

For disposal, regulatory documents instruct patients to ask a healthcare professional how to properly discard any unused or outdated medicine. This may involve using authorized drug take-back locations or mail-back programs.